Neurocrine Biosciences recently initiated a Phase 2 randomized, double-blind, placebo-controlled trial of NBI-1065890, a next-generation selective VMAT2 inhibitor, in about 100 adults with tardive ...

One of the largest autism trials of leucovorin (Wellcovorin), a drug used to treat cerebral folate deficiency, was retracted ...

Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous EGFR-Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial One ...

With no approved pediatric treatments, Lin wonders whether Serena will be able to attend college. As a community representative for the U.S. National Institutes of Health’s long COVID clinical trials ...

POTOMAC, MARYLAND / / February 2, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), today reported it ...

Medically reviewed by Kate Colby, MPH Key Takeaways In a double-blind trial, neither the patient nor the researcher knows who gets the treatment.A placebo-controlled trial uses a fake drug to test ...

“The topline results from Ascletis’ Phase 3 open-label acne trial in China build additional confidence in the clinical potential of FASN inhibition in acne,” said David Happel, Chief Executive Officer ...